Recent Quotes (30 days)

You have no recent quotes
chg | %

RWS Holdings plc  

(Public, LON:RWS)   Watch this stock  
Find more results forRWS
-0.23 (-0.05%)
Feb 16 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 294.50 - 569.04
Open     -
Vol / Avg. 0.00/236,280.00
Mkt cap 1,208.47M*
P/E 40.66
Div/yield 5.20*
EPS 0.11*
Shares 273.24M
Beta     -
Inst. own     -
Feb 14, 2018
RWS Holdings PLC Annual Shareholders Meeting (Estimated)
Feb 13, 2018
RWS Holdings PLC Annual Shareholders Meeting
Dec 6, 2017
Full Year 2017 RWS Holdings PLC Earnings Call
Dec 6, 2017
Full Year 2017 RWS Holdings PLC Earnings Release

Key stats and ratios

Q3 (Sep '17) 2017
Net profit margin 15.90% 14.97%
Operating margin 22.90% 20.72%
EBITD margin - 27.26%
Return on average assets 12.00% 12.37%
Return on average equity 17.82% 18.36%
Employees 908 -
CDP Score - -


Europa House Chiltern Park, Chiltern Hill
United Kingdom - Map
+44-1753-480200 (Phone)
+44-1753-480280 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


RWS Holdings plc is a holding company, which provides patent translations, intellectual property support services, technical and commercial translations and linguistic validation services, through its subsidiaries. The Company's segments include Patent translation division, Life science division, Commercial division and Information division. The Patent translation division provides patent and technical document translation and filing services with offices in the United Kingdom, the United States, Europe, Japan and China. The Life science division provides technical translations and linguistic validation to medical and pharmaceutical sector. The Life science division includes Corporate Translations Inc., and medical translation and Pharmaquest linguistic validation businesses. The Commercial division provides non patent technical translation and localization services. The Information division offers patent search, retrieval and monitoring services, and patent database service, PatBase.

Officers and directors

Andrew Stephen Brode Executive Chairman of the Board
Age: 67
Richard Thompson Chief Executive Officer
Age: 53
Desmond Glass Chief Financial Officer
Age: 47
David E. Shrimpton Senior Non-Executive Independent Deputy Chairman of the Board
Age: 71
Elisabeth A. Lucas Non-Executive Director
Age: 59
Lara Boro Non-Executive Independent Director